ANDA 73310, held by Sun Pharm Industries. Tolmetin Sodium.
As of Nov 16, 2026, ANDA 73310 (Tolmetin Sodium), held by Sun Pharm Industries, was first approved by FDA on Nov 27, 1991, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 27, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tolmetin SodiumEQ 200MG BASE · tablet;oral | Tolmetin Sodium | Discontinued |
| May 9, 2016 | Supplement 22Labeling · Standard review | Approved | None posted |
| Apr 3, 2008 | Supplement 19Labeling | Approved | None posted |
| May 16, 2006 | Supplement 18Labeling | Approved | None posted |
| Jun 14, 2002 | Supplement 7Manufacturing | Approved | None posted |
| May 16, 2000 | Supplement 5Manufacturing | Approved | None posted |
| May 16, 2000 | Supplement 6Manufacturing | Approved | None posted |
| Dec 5, 1997 | Supplement 4Manufacturing | Approved | None posted |
| Feb 24, 1997 | Supplement 3Manufacturing | Approved | None posted |
| Jun 22, 1995 | Supplement 2Manufacturing | Approved | None posted |
| Jan 12, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Nov 27, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters